EP4457009A1 - Method for simultaneous preparation of separated enantiomeric products from racemic or scalemic substrates - Google Patents
Method for simultaneous preparation of separated enantiomeric products from racemic or scalemic substratesInfo
- Publication number
- EP4457009A1 EP4457009A1 EP22847128.0A EP22847128A EP4457009A1 EP 4457009 A1 EP4457009 A1 EP 4457009A1 EP 22847128 A EP22847128 A EP 22847128A EP 4457009 A1 EP4457009 A1 EP 4457009A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- mixture
- membrane
- racemic
- enantiomer
- enantiomers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/007—Separation by stereostructure, steric separation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/70—Polymers having silicon in the main chain, with or without sulfur, nitrogen, oxygen or carbon only
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/24—Stationary reactors without moving elements inside
- B01J19/2475—Membrane reactors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
- C07C29/10—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
- C07C29/103—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers
- C07C29/106—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers of oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/18—Polyhydroxylic acyclic alcohols
- C07C31/20—Dihydroxylic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/26—Further operations combined with membrane separation processes
- B01D2311/2696—Catalytic reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/36—Hydrophilic membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/38—Hydrophobic membranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the present invention relates to methods for producing both separated enantiomers from a racemic or scalemic substrate and to devices for performing such methods.
- Enantiomers are defined as compounds having the same molecular formula and have identical chemical and physical properties except for their ability to rotate plane- polarized light (+/-) by equal amounts but in opposite directions.
- Enantiomers - also named "optical isomers” - have at least one chiral element (stereogenic centre atom, axial, planar, helical or inherent chirality), for instance a stereogenic carbon, and the structures of the 2 enantiomers are each a mirror image of each other but these images are not superimposable.
- the amounts of the different kinds of enantiomer in the mixture are not identical.
- Such mixture is a scalemic mixture.
- Kinetic resolution involves the transformation of one of the enantiomers of a racemic mixture: the conversion should not be higher than 50% of the mixture.
- Sato et al (Angew. Chem. Int. Ed 2015) reports cooperative catalysis involving two successive reactions to convert enantioselectively styrene into 1 -phenylethanol ; the catalyst of the first reaction is not compatible with the enzyme of the second reaction, and the first reaction is therefore conducted in a PDMS thimble, allowing the product of this first reaction to diffuse in a second compartment. This system is intended to obtain only one enantiomer.
- Vedejs et al (J. Am. Chem. Soc. 1997, 2584 - 2585) is reporting parallel kinetic resolution of a racemic substrate.
- Two quasi enantiomers reagents are used to perform 2 reactions in the same medium.
- the products such obtained are not mirror images of each other; subsequent steps have to be performed to separate them, and the method cannot be performed continuously.
- WO 2006/087556 is relating to a process for separating enantiomers or isomers through formation and subsequent decomposition of host-guest complex coupled to membrane nanofiltration.
- One enantiomer has a higher affinity for the host molecule, and could be then separated by adding subsequent solvents in order to recover the enantiomer.
- US 5077217 is relating to methods for enzymatic resolution of racemic mixture of esters.
- One of the enantiomers is selectively derivatized with group enhancing the aqueous solubility, by an enzymatic catalyzed reaction.
- the so prepared derivative is then separated from the reaction medium by diffusion through a membrane.
- the present invention relates to a method for obtaining at least a first separated mixture optically enriched in a first enantiomer B' and second separated mixture optically enriched in a second enantiomer B" from a starting racemic or scalemic mixture of enantiomers A' and A" in liquid medium, wherein the polarity of the starting racemic or scalemic mixture is different from the polarity of each of the first and second enantiomers B' and B" present in the separated first and second mixtures and, wherein the separated enantiomers B' and B" present in the separated mixtures are resulting of selective catalytic reactions carried out on the starting racemic or scalemic mixture in at least two separate compartments of a vessel, said two compartments being separated by a membrane allowing the diffusion of the starting racemic or scalemic mixture, said starting racemic or scalemic mixture being present in all the compartments of the vessel, and the membrane being impermeable to the first and second enantiomers B' and B" resulting from the reaction.
- the starting racemic mixture is containing an equal amount of enantiomers A' and A" of a starting compound (or molecule) A.
- the starting scalemic mixture is containing enantiomer A' and A" respectively in different amounts, i.e. the concentration of one enantiomer is greater than 50% of the mixture and the concentration of the other enantiomer is smaller than 50% of the mixture.
- the ratio between the 2 compounds in the starting scalemic mixture can be 70/30, in particular 60/40.
- the invention will in particular be adapted for starting scalemic mixture wherein the ratio of enantiomers A and A” is from 60/40 to 51/49.
- the ratio between the 2 enantiomers can be from 60/40 to 50/50.
- the separated mixtures, resulting from the reaction contain a mixtures of enantiomers B' and B" of a product (or molecule) B. However, the amount of enantiomer respectively B' and B" in these mixtures is not equal, each of the said first and second separated mixtures is enriched respectively in one of the two opposite enantiomers B' and B".
- the starting racemic or scalemic mixture is present in all the compartment of the vessel, since the polarity of the enantiomers A' and A" is allowing their passage throughout the membrane; the polarity of the resulting enantiomers B' and B" is not allowing the passage throughout the membrane: the mixture enriched in a first enantiomer B' will therefore remain separated from the mixture enriched in the second enantiomer B".
- the invention also relates to the use of a membrane which is permeable to the enantiomers A' and A" (of a molecule A) present in a starting racemic or scalemic mixture, for isolating on one side of said membrane a mixture optically enriched in a first enantiomer B' and on the other side of the membrane a mixture optically enriched in a second enantiomer B", the first and the second enantiomer B' and B" resulting of a reaction carried out on the starting racemic or scalemic mixture, the polarity of the starting racemic or scalemic mixture A being different from the polarity of the first and the second enantiomers B' and B" resulting from the reaction.
- the invention is also directed to a method for obtaining, in liquid medium, a first and a second separated enantiomers B' and B" from a racemic or scalemic mixture A, wherein the polarity of the racemic or scalemic mixture A is different from the polarity of each of the first and the second separated enantiomers B' and B", the racemic or scalemic mixture A being placed in a vessel containing a membrane defining at least a first and a second compartments, the membrane being permeable to the racemic or scalemic mixture A, the first and the second separated enantiomers B' and B" being obtained by carrying out the same reaction with opposite enantioselectivity in the first and the second compartments respectively on the racemic or scalemic mixture A, in order to produce the first separated enantiomer in the first compartment and the second enantiomer in the second compartment, the membrane being impermeable to the first and the second separated enantiomers B' and B" of B.
- the starting mixture is a racemic mixture.
- the reaction carried out in the first compartment is catalyzed by a first catalyst and the reaction carried out in the second compartment is catalysed by a second catalyst with opposite enantioselectivity, the first catalyst being an enantioselective catalyst allowing the production of the first separated enantiomer B' and the second catalyst being an enantioselective catalyst allowing the production of the second separated enantiomer B".
- the composition of the liquid medium is similar on the two sides of the membrane, and has a similar polarity, and the same pH.
- the racemic or scalemic mixture A could bear functional groups conferring a hydrophilic/hydrophobic balance or a polarity allowing the passage of the molecules through the diffusion membrane.
- the concentration of the racemic or scalemic mixture A on both sides of the membrane will therefore be equilibrated via the diffusion phenomenon.
- the polarity of the separated enantiomers of B will be different from the polarity of the racemic or scalemic mixture A.
- enantioselective reactions are performed on the racemic or scalemic mixture A; preferably the reactions are performed simultaneously in each of the different compartments of the vessel.
- These catalytic reactions are activated with chiral catalysts and are leading respectively to the formation of opposite enantiomers in each of said compartments.
- the chiral catalysts are preferably optically pure.
- said two chiral catalysts cannot pass through the membrane; in particular, the chiral catalysts have a polarity which is not allowing their diffusion through the membrane separating the different compartments.
- the polarity of said chiral catalysts is similar to the polarity of the separated resulting enantiomers.
- the said two chiral catalysts are immobilized on a support, not allowing the diffusion through the membrane.
- Said chiral catalysts have opposite enantioselectivity.
- the chiral catalyst activates the transformation of a functional group on the racemic substrate A present in the mixture, to obtain a different functional group, having a polarity different from the polarity of the starting material. Since each of the catalyst is present in a different compartment, the modification of the functional group will occur preferably on a single enantiomer A' or A" of the racemic or scalemic substrate A.
- the said mixture optically enriched in one enantiomer of B remains in the compartment defined by the diffusion membrane and is therefore separated from the mixture optically enriched its opposite enantiomer, which has been formed by the reaction in the other compartment of the vessel.
- the starting racemic or scalemic starting mixtures A can continuously diffuse through the membrane, so ensuring an optimal concentration of the substrate and allowing a full conversion of the racemic mixture. The yield of the reaction is therefore improved.
- reaction of transformation of the functional group is rapid on the selected enantiomer.
- rate of the reactions conducted in parallel are similar.
- the conversion rate can be as high as 88% in each compartment.
- the concentration of the separated enantiomer resulting from the reaction is therefore high in each compartment.
- the compartments are separated by a membrane having selective permeability, depending on the polarity of the substrate and of the polarity of the reaction products.
- the racemic or scalemic substrate A can go through the membrane, but the products B of the reaction in each compartment cannot diffuse through the membrane.
- Another advantage of the invention is the use of a chiral supplementary molecule as a catalyst, and not as a reagent. This allows to use only small amount of these agents with respect to the enantiomers of interest. This is both cost-effective and advantageous in terms of sustainability.
- the membranes for use in the invention may be selected from regenerated cellulose, the esters of cellulose, polyacrylonitrile, polyacrylonitrile copolymers, polyurethane- containing copolymers, polyarylsulfones, polyarylethersulfones, polyarylsulfone blends, polyaryethersulfone blends, polyvinylidene fluoride, polytetrafluoroethylene, polyvinylalcohol, aliphatic polyamides, aromatic polyamides, polyimides, polyetherimides, polyesters, polycarbonates, polyolefins, polybenzimidazole, and polybenzimidazolone. More particularly, the membranes are selected from polydimethylsiloxane membrane and modified polydimethylsiloxane membranes by surface modification or incorporation of nanocomposite (mixed matrix membrane).
- the use and method of the invention can in particular comprise the following steps: a) Providing in a first fluid a starting racemic or scalemic mixture to one side of a diffusion membrane selective according to the polarity of the compounds, and providing in a second fluid the same starting racemic or scalemic mixture to the opposite side of said diffusion membrane, the polarity of the enantiomers A' and A" of the starting racemic or scalemic mixture allowing their diffusion through the diffusion membrane, b) Providing in the first fluid containing the starting or scalemic racemic mixture a first catalyst, said first catalyst activating the transformation of the racemic or scalemic mixture into a first mixture enriched in a product B’ which is a first enantiomer, and providing in the second fluid containing the racemic or scalemic mixture a second catalyst, said second catalyst activating the transformation of the racemic or scalemic mixture into a second mixture enriched in a product B” which is a second enantiomer opposite to the enantiomer B’ obtained with the first catalyst, wherein the polar
- the first catalyst preferably optically pure, is mainly transforming the starting racemic or scalemic mixture into a first enantiomer B'.
- a small part of the starting racemic or scalemic mixture may be transformed into the second enantiomer B". This second reaction will occur at very low level, therefore, the composition of the mixture in the compartment will comprise principally enantiomer B'.
- the same phenomenon may occur with the second catalyst, also preferably optically pure, which is mainly resulting in obtaining the second enantiomer B"; but a small part of the starting racemic or scalemic mixture is transformed into the first enantiomer B'.
- the optical purity is defined as the ratio of the observed optical rotation of a sample consisting of a mixture of enantiomers to the optical rotation of one pure enantiomer.
- Enantiomerically enriched corresponds to a sample of a chiral substance whose enantiomeric ratio is greater than 50:50 but less than 100:0.
- optically pure is intended a compound which is enantiomerically pure (or enantiopure), i.e. a sample all of whose molecules have the same chirality sense.
- optically enriched in one enantiomer is intended a mixture comprising one enantiomer of the molecule in an amount higher than the amount of the opposite enantiomer of the same molecule. This is therefore different from racemic mixtures, wherein in the amounts of the 2 enantiomers are equal.
- a mixture of enantiomers optically enriched in one enantiomer B' is comprising at least 51 % of said enantiomer, based on the total amount of enantiomers (B' and B").
- a mixture optically enriched in one enantiomer is comprising at least 55% of said enantiomer, in particular at least 60%, and preferably at least 70% of the enantiomer.
- the mixture optically enriched in one enantiomer is comprising an amount equal or greater than 80% of said enantiomer, and possible at least 99,9% of the enantiomer, based on the total amount of enantiomers of the molecule.
- a mixture optically enriched in one enantiomer will comprise at least 2% of excess of said enantiomer over the other enantiomer, in particular it comprises at least 10%, at Ieast15% or at least 20 % more of the said enantiomer when compared to the other enantiomer.
- the enantiomeric excess is preferably greater or equal to 60%, in particular greater or equal to 70%, and could be greater or equal to 90%.
- the enantiomeric excess in the enriched mixture is therefore generally comprised between 2% and 100%, in particular between 10% and 100% with respect to the opposite enantiomer.
- the mixture on one side of the membrane the mixture may therefore comprise between 65% and 100% of the first enantiomer, based on the total amount of enantiomers; on the other side of the membrane, the mixture may comprise between 65% and 100% of the second enantiomer, based on the total amount of enantiomers.
- the enantiomeric excess (ee) is a measure of the enantiomeric purity of a chiral compound. It is defined (in percents) by the following formula:
- the mixture obtained in each compartment comprises preferably at least 2% more of the respective enantiomer than in the starting scalemic mixture.
- the transformation of the enantiomers present in the starting racemic or scalemic mixture may in particular be a hydrolysis, but is not limited to such reaction.
- Other transformations involve a reaction selected from dihydroxylation, reduction of ketones, esterification or alkylation.
- the starting racemic or scalemic mixture A is less polar than the products B of the catalytic reactions.
- the membrane is hydrophobic.
- the invention relates in particular to use of a membrane and to methods for separating enantiomers as described above, wherein the starting racemic or scalemic mixture is non-polar and the diffusion membrane is a hydrophobic membrane.
- the first enantiomer B’ and the second enantiomer B” are in such embodiments, polar products.
- the catalysts used respectively to activate the conversion of the starting racemic mixture into a polar product are polar too.
- the method and use according to the invention may comprise the following steps: a) Providing in a first fluid a starting racemic or scalemic mixture to one side of a hydrophobic diffusion membrane, and providing in a second fluid the same starting racemic or scalemic mixture to the opposite side of said hydrophobic diffusion membrane, wherein the enantiomers of the racemic or scalemic mixture are not polar such allowing their diffusion through the diffusion membrane, b) Providing in the first fluid containing the starting racemic or scalemic mixture a first catalyst, preferably a first optically pure catalyst, said first catalyst activating the transformation of the racemic or scalemic mixture into a first mixture optically enriched in a product B’ which is an enantiomer, and providing in the second fluid containing the starting racemic or scalemic mixture a second catalyst, preferably a second optically pure catalyst ,said second catalyst activating the transformation of the racemic or scalemic mixture into a second mixture optically enriched in a product B” which is an enantiomer opposite to the enantio
- the chiral catalyst activates the transformation of a functional group on the racemic substrate present in the mixture, to obtain a different functional group, which is more polar on the resultant enantiomer product; the resultant enantiomer is not allowed to diffuse through the hydrophobic membrane, and remains in the compartments where it was produced.
- the chiral catalyst used for the transformation can in particular be a Jacobsen catalyst.
- the diffusion membrane may be in particular a hydrophobic polydimethylsiloxane (PDMS) membrane.
- PDMS polydimethylsiloxane
- PDMS membrane is selectively permeable to apolar molecules and impermeable to polar molecules.
- Hydrophobic PDMS membranes are known in the art and will be readily purchased or prepared by the man skilled in the art. They were disclosed for instance by Sato et al (2015).
- Membranes adapted for implementing the invention may be prepared from the precursors of membranes commercialized under the trade name Sylgard 184.
- Such membranes are notably dense non-porous membranes. They are inter alia, used for ultra-filtration and permeation for the purification of water.
- the racemic or scalemic mixture is polar and the diffusion membrane is an hydrophilic membrane.
- the first enantiomer B’ and the second enantiomer B” are, in such embodiments, non-polar products, or at least products which are less polar than the starting racemic or scalemic mixture.
- the catalysts used respectively to activate the conversion of the starting racemic or scalemic mixture into a non-polar product are under a form not allowing their passage through the hydrophilic diffusion membrane. Catalysts may be for instance immobilized on a support, or treated to avoid their passage.
- Such support may for instance be selected from silica, polystyrene or tentagel® resin.
- the method and use will typically comprise the following steps: a) Providing in a first fluid a starting racemic or scalemic mixture to one side of a hydrophilic diffusion membrane, and providing in a second fluid the same starting racemic or scalemic mixture to the opposite side of said hydrophilic diffusion membrane, wherein the enantiomers of the racemic or scalemic mixture are polar such allowing their diffusion through the diffusion membrane, b) Providing in the first fluid containing the starting racemic or scalemic mixture a first optically pure catalyst, said first catalyst activating the transformation, in particular by hydrolysis, of the racemic or scalemic mixture into a first mixture optically enriched in a product B’ which is an enantiomer, and providing in the second fluid containing the racemic or scalemic mixture a second optically pure catalyst, said second catalyst activating the transformation, in particular by hydrolysis, of the racemic or scalemic mixture into a second mixture optically enriched in
- Hydrophilic membranes are also known in the art. Such membranes are for instance derivatized or functionalized PDMS membranes, where the PDMS is modified by surface functionalization, in particular via glycan surface functionalization (as disclosed by Esteba-Tejeda et al, Polymer, 2016, 1 - 7).
- the method of compartmentalized kinetic resolution according to the invention can be performed with various catalytic reactions, as far as the polarity of the product is different from the polarity of the starting racemic material.
- racemic substrates are bearing at least a functional group which is modified by the catalytic reaction in a functional group having a different polarity.
- reaction on the racemic mixture can be for instance selected from dihydroxylation reactions of alkene and epoxide ring-opening reactions.
- the reaction activated by the said chiral catalysts may be the transformation of an epoxide structure present on the racemic mixtures, which is opened to give alcoholic functions.
- Such reaction can be catalyzed by a complex of cobalt.
- Each chiral form of the complex will selectively catalyze the reaction of one of the enantiomers.
- the use of the permeable membranes and the methods of the invention can be realized in continuous process. That is the optically enriched separated enantiomers are recovered from the corresponding compartment defined by the membrane, while the reactions on the racemic mixtures are performed, such leading to renewed amounts of modified optically pure enantiomers. Racemic or scalemic mixtures can be feed at another part of the vessel, in order to have substrate for the catalytic reactions.
- the use of the permeable membranes and the methods of the invention are realized as batch process.
- the invention will be performed in a compartmentalized reactor.
- Said reactor employs a membrane reactor/separator system which allows racemic reaction mixture or phase circulating in contact with each side of a membrane.
- Reactors useful for the invention are commercialized for instance by SES GmbH- Analytical systems.
- the ratio between the volume of the compartments and surface of the membrane will be adapted, according to the polarity of the starting racemic mixtures and of the enantiomers resulting from the enantioselective reaction.
- the methods of the invention are particularly useful for obtaining mixtures optically enriched in desired enantiomers in pharmaceutical applications ; possibly, optically pure enantiomers will be separated from the enriched mixtures.
- the methods of the invention are also useful for obtaining mixtures optically enriched in desired enantiomers and optically pure enantiomers in the agrochemical or food industry, or in any field requiring high optical purity of the compounds.
- enantiomers which have different properties depending on their optical form and could benefit from separation include but are not limited to propoxyphene, of which R form is an analgesic, while its S form is an anticough.
- Levodropropizine is effective as an antitussive, but appears to carry a lower risk of daytime somnolence than dropropizine.
- Propranolol has a beta-blocking action, and the S form is approximately 100 times more active than the R form.
- the ( ?)-isomer of salbutamol, a broncho dilatating drug has 150 times greater affinity for the beta2- receptor than the (S)-isomer and the (S)-isomer has been associated with toxicity.
- Mephenesine and methocarbamol also exhibits different levels of activity, depending in the optical form, and could benefit from the separation method according to the invention.
- FIG. 1 schematic representation of the steps of the compartmentalized enantioselective multicatalytic resolution.
- FIG. 2 resolution of an epoxy enantiomer with a chiral catalyst complex of cobalt
- FIG. 3 reactor 1 for implementing the catalytic separation
- Precuring The elastomer and curing agent (Sylgard 184) were mixed and then the casting solution was degassed in a desiccator under vacuum for 2 hours.
- Reactor 1 The effective area of membrane is 0.95 cm 2 and each compartment (C1 was the left and C2 was the right) has a volume of 10 mL. (0.095 cm 2 /mL)
- Reactor 2 The effective area of membrane is 11.34 cm 2 and each compartment has a volume of 50 mL. (0.2268 cm 2 /mL)
- Reactor 3 This reactor was purchased from PERME GEAR. The effective area of membrane is 1.13 cm 2 and each compartment has a volume of 5 mL. (0.226 cm 2 /mL).
- the Co(ll) complex 1 (0.12 g, 0.2 mmol) was dissolved in toluene (1 mL, 0.2 M), then acetic acid (229 mL, 0.4 mmol, 2 equiv.) was added. The mixture was stirred open to air at room temperature for 1 h, during which the color of the mixture changed from red to dark red. In the end, toluene was removed by vacuum evaporation and 1 xQAc was obtained.
- styrene oxide (4.81 g, 40 mmol, 1 equiv.) and (S,S)-catalyst 1- OAc (0.13 g, 0.2 mmol, 0.5 mol %) were introduced with 3 mL of CH3CN while in C2, the same amount of styrene oxide (4.81 g, 40 mmol, 1 equiv.) were introduced but with (R,R)- catalyst 1-OAc (0.13 g, 0.2 mmol, 0.5 mol %) with 3 mL of CH3CN.
- H2O 864 mL, 48 mmol, 1.2 equiv.
- styrene oxide (4.81 g, 40 mmol, 1 equiv.) and (S,S)-catalyst 1- OAc (0.13 g, 0.2 mmol, 0.5 mol %) were introduced with 3 mL of CH3CN while in C2, the same amount of styrene oxide (4.81 g, 40 mmol, 1 equiv.) were introduced but with (R,R)- catalyst 1-OAc (0.13 g, 0.2 mmol, 0.5 mol %) with 3 mL of CH3CN.
- H2O 864 pL, 48 mmol, 1.2 equiv.
- styrene oxide (2.40 g, 20 mmol, 1 equiv.) and (S,S)-catalyst 1- OAc (0.06 g, 0.1 mmol, 0.5 mol %) were introduced with 5.5 mL of CH3CN while in C2, the same amount of styrene oxide (2.40 g, 20 mmol, 1 equiv.) were introduced but with (R,R)-catalyst 1 -OAc (0.06 g, 0.1 mmol, 0.5 mol %) with 5.5 mL of CH3CN.
- H2O 32 pL, 24 mmol, 1.2 equiv.
- the reaction mixture was then allowed to warm at room temperature.
- the conversion in the double reactor reached 69 % in 120 h.
- the ee of diol in Ci and C2 were 87 % and 88 % in 120 h respectively.
- styrene oxide (1.20 g, 10 mmol, 1 equiv.) and (S,S)-catalyst 1- OAc (0.03 g, 0.05 mmol, 0.5 mol %) were introduced with 9 mL of CH3CN while in C2, the same amount of styrene oxide (1.20 g, 10 mmol, 1 equiv.) were introduced but with (R,R)-catalyst 1 -OAc (0.03 g, 0.05 mmol, 0.5 mol %) with 9 mL of CH3CN.
- H2O 216 pL, 12 mmol, 1 .2 equiv.
- the reaction mixture was then allowed to warm at room temperature.
- the conversion in the double reactor reached 52 % in 168 h.
- Each compartment was purified separately by chromatography on silica gel (ethylacetate/petroleum ether: 5/5 v/v).
- Enantioenriched diol from Ci was obtained with 37 % isolated yield in 80 % ee. From C2, the configurationally opposite diol was obtained with 32 % isolated yield in 83 % ee.
- styrene oxide (28.86 g, 240 mmol, 1 equiv.) and (S,S)-catalyst 1 -OAc (0.78 g, 1 .2 mmol, 0.5 mol %) were introduced with 18 mL of CH3CN while in C2, the same amount of styrene oxide (28.86 g, 240 mmol, 1 equiv.) were introduced but with (R,R)-catalyst 1-OAc (0.78 g, 1.2 mmol, 0.5 mol %) with 18 mL of CH3CN.
- styrene oxide (4.81 g, 40 mmol, 1 equiv.) and (S,S)-catalyst 1- OAc (0.13 g, 0.2 mmol, 0.5 mol %) were introduced with 3 mL of CH3CN while in C2, the same amount of styrene oxide (4.81 g, 40 mmol, 1 equiv.) were introduced but with (R,R)- catalyst 1-OAc (0.13 g, 0.2 mmol, 0.5 mol %) with 3 mL of CH3CN.
- H2O (864 pL, 48 mmol, 1.2 equiv.) was added dropwise at 0 °C. The reaction mixture was then allowed to warm at room temperature. The conversion in the double reactor reached 81 % in 144 h. The ee of diol in Ci and C2 were 83 % and 87 % in 144 h respectively.
- styrene oxide (2.4 g, 20 mmol, 1 equiv.) and (S,S)-catalyst 1- OAc (0.06 g, 0.1 mmol, 0.5 mol %) were introduced with 1.5 mL of CH3CN while in C2, the same amount of styrene oxide (2.4 g, 20 mmol, 1 equiv.) were introduced but with (R,R)-catalyst 1 -OAc (0.06 g, 0.1 mmol, 0.5 mol %) with 1.5 mL of CH3CN.
- H2O (432 pL, 24 mmol, 1 .2 equiv.) was added dropwise at 0 °C.
- allyl glycidyl ether (2.42 g, 21 .2 mmol, 1 equiv.) OH and (S,S)-catalyst 1 -OAc (0.06 g, 0.1 mmol, 0.5 mol %) were introduced with 1.5 mL of CH3CN while in C2, the same amount of allyl glycidyl ether (2.42 g, 21.2 mmol, 1 equiv.) were introduced but with (R,R)-catalyst 1 -OAc (0.06 g, 0.1 mmol, 0.5 mol %) with 1 .5 mL of CH3CN.
- H2O (457 pL, 25.4 mmol, 1 .2 equiv.) was added dropwise at 0 °C.
- a balloon with air (P 1 atm) was placed on the top of both compartments.
- the reaction mixture was then allowed to warm at room temperature.
- Each compartment is purified separately by chromatography on silica gel (ethylacetate/ petroleum ether: 5/5 v/v). The conversion in the double reactor reached 93 % in 72 h.
- Enantioenriched diol from Ci was obtained with 73 % isolated yield in 71 % ee.
- From C2 the configurationally opposite diol was obtained with 71 % isolated yield in 69 % ee.
- H2O (457 pL, 25.4 mmol, 1.2 equiv.) was added dropwise at 0 °C.
- a balloon with air (P 1 atm) was placed on the top of both compartments.
- the reaction mixture was then allowed to warm at room temperature.
- Each compartment is purified separately by chromatography on silica gel (ethylacetate/ petroleum ether: 5/5 v/v).
- the conversion in the double reactor reached 80 % in 72 h.
- Enantioenriched diol from Ci was obtained with 56 % isolated yield in 81 % ee.
- From C2 the configurationally opposite diol was obtained with 57 % isolated yield in 77 % ee.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306951 | 2021-12-29 | ||
| PCT/EP2022/085983 WO2023126186A1 (en) | 2021-12-29 | 2022-12-14 | Method for simultaneous preparation of separated enantiomeric products from racemic or scalemic substrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4457009A1 true EP4457009A1 (en) | 2024-11-06 |
Family
ID=80113179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22847128.0A Pending EP4457009A1 (en) | 2021-12-29 | 2022-12-14 | Method for simultaneous preparation of separated enantiomeric products from racemic or scalemic substrates |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4457009A1 (en) |
| WO (1) | WO2023126186A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800162A (en) | 1987-04-01 | 1989-01-24 | Sepracor, Inc. | Method for resolution of steroisomers in multiphase and extractive membrane reactors |
| GB2423300A (en) | 2005-02-17 | 2006-08-23 | Membrane Extraction Tech Ltd | Separating enantiomers & isomers by formation, separation & decomposition of host-guest complex, & separation of host & guest molecules with membrane |
| AU2007288122A1 (en) * | 2006-08-25 | 2008-02-28 | The University Of Sydney | Reaction system |
-
2022
- 2022-12-14 EP EP22847128.0A patent/EP4457009A1/en active Pending
- 2022-12-14 WO PCT/EP2022/085983 patent/WO2023126186A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023126186A1 (en) | 2023-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hodge | Organic synthesis using polymer-supported reagents, catalysts and scavengers in simple laboratory flow systems | |
| Li | Chiral synthesis on catalysts immobilized in microporous and mesoporous materials | |
| Lorenz et al. | Processes to separate enantiomers | |
| Sienkiewicz et al. | The unique activity of catalyst in the epoxidation of soybean oil and following reaction of epoxidized product with bisphenol A | |
| Bräse et al. | Recent Advances in Asymmetric C C and C‐Heteroatom Bond Forming Reactions using Polymer‐Bound Catalysts | |
| EP2114853B1 (en) | Process for preparing glycerol esters | |
| Fellechner et al. | Reactive separations for in situ product removal of enzymatic reactions: a review | |
| Higashio et al. | Continuous‐Flow Dynamic Kinetic Resolution of Racemic Alcohols by Lipase–Oxovanadium Cocatalysis | |
| Parvulescu et al. | Heterogeneous catalysts for racemization and dynamic kinetic resolution of amines and secondary alcohols | |
| Aerts et al. | Recycling of the homogeneous Co-Jacobsen catalyst through solvent-resistent nanofiltration (SRNF) | |
| Oláh et al. | Lipase B from Candida antarctica immobilized on epoxy-functionalized hollow silica microspheres: efficient biocatalysts for enantiomer selective acylation of alcohols and amines | |
| Liu et al. | One-pot CuI/DBU-catalyzed carboxylative cyclization toward oxazolidinones using recyclable molecular sieves as efficient promoters for fixation of CO2 in water medium | |
| BR112014000885B1 (en) | production process of an aliphatic ester of lactic acid and an aliphatic ester of lactic acid | |
| Petrusová et al. | Microreaction and membrane technologies for continuous single-enantiomer production: A review | |
| Choi et al. | Enantioselective hydrolytic kinetic resolution of epoxides catalyzed by chiral Co (III) salen complexes immobilized in the membrane reactor | |
| Solodenko et al. | Continuous enantioselective kinetic resolution of terminal epoxides using immobilized chiral cobalt-salen complexes | |
| EP4457009A1 (en) | Method for simultaneous preparation of separated enantiomeric products from racemic or scalemic substrates | |
| CN110003005A (en) | The method for preparing chiral beta-hydroxy carboxylate compound | |
| Carreiro et al. | Continuous flow enantioselective processes catalysed by cinchona alkaloid derivatives | |
| EP0605173A2 (en) | Hollow fibre reactor | |
| Benessere et al. | Rational design of pseudo-enantiomeric libraries of ligands based on pyranoses for application in asymmetric catalysis | |
| García‐Verdugo et al. | Biocatalytic processes based on supported ionic liquids | |
| Paolucci-Jeanjean et al. | Biomolecule applications for membrane-based phase contacting systems: distribution, separation and reaction—a first state of the art | |
| Tungler et al. | Asymmetric heterogeneous catalytic hydrogenation, is it a useful tool for the synthetic organic chemist | |
| US5514818A (en) | Resolution of stereoisomers of aliphatic epoxides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20240628 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20250725 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |